These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Daily versus weekly azithromycin in cystic fibrosis patients. McCormack J; Bell S; Senini S; Walmsley K; Patel K; Wainwright C; Serisier D; Harris M; Bowler S Eur Respir J; 2007 Sep; 30(3):487-95. PubMed ID: 17537764 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic drug monitoring of once daily tobramycin in cystic fibrosis--caution with trough concentrations. Coulthard KP; Peckham DG; Conway SP; Smith CA; Bell J; Turnidge J J Cyst Fibros; 2007 Apr; 6(2):125-30. PubMed ID: 16829216 [TBL] [Abstract][Full Text] [Related]
6. Azithromycin maintenance therapy in patients with cystic fibrosis: a dose advice based on a review of pharmacokinetics, efficacy, and side effects. Wilms EB; Touw DJ; Heijerman HG; van der Ent CK Pediatr Pulmonol; 2012 Jul; 47(7):658-65. PubMed ID: 22684985 [TBL] [Abstract][Full Text] [Related]
7. Long term azithromycin therapy in cystic fibrosis patients: a study on drug levels and sputum properties. Baumann U; King M; App EM; Tai S; König A; Fischer JJ; Zimmermann T; Sextro W; von der Hardt H Can Respir J; 2004 Mar; 11(2):151-5. PubMed ID: 15045047 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of azithromycin in plasma and sinus mucosal tissue following administration of extended-release or immediate-release formulations in adult patients with chronic rhinosinusitis. Fang AF; Palmer JN; Chiu AG; Blumer JL; Crownover PH; Campbell MD; Damle BD Int J Antimicrob Agents; 2009 Jul; 34(1):67-71. PubMed ID: 19307106 [TBL] [Abstract][Full Text] [Related]
13. Comparative pharmacokinetics of azithromycin in serum and white blood cells of healthy subjects receiving a single-dose extended-release regimen versus a 3-day immediate-release regimen. Liu P; Allaudeen H; Chandra R; Phillips K; Jungnik A; Breen JD; Sharma A Antimicrob Agents Chemother; 2007 Jan; 51(1):103-9. PubMed ID: 17060516 [TBL] [Abstract][Full Text] [Related]
14. Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients. Hansen CR; Pressler T; Hoiby N; Johansen HK J Cyst Fibros; 2009 Jan; 8(1):58-62. PubMed ID: 18849202 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic modelling of a once-daily dosing regimen for intravenous tobramycin in paediatric cystic fibrosis patients. Lam W; Tjon J; Seto W; Dekker A; Wong C; Atenafu E; Bitnun A; Waters V; Yau Y; Solomon M; Ratjen F J Antimicrob Chemother; 2007 Jun; 59(6):1135-40. PubMed ID: 17446242 [TBL] [Abstract][Full Text] [Related]
16. Autoantibodies against bactericidal/permeability-increasing protein (BPI-ANCA) in cystic fibrosis patients treated with azithromycin. Rotschild M; Elias N; Berkowitz D; Pollak S; Shinawi M; Beck R; Bentur L Clin Exp Med; 2005 Jul; 5(2):80-5. PubMed ID: 16096858 [TBL] [Abstract][Full Text] [Related]
17. Comparative distribution of azithromycin in lung tissue of patients given oral daily doses of 500 and 1000 mg. Danesi R; Lupetti A; Barbara C; Ghelardi E; Chella A; Malizia T; Senesi S; Angeletti CA; Del Tacca M; Campa M J Antimicrob Chemother; 2003 Apr; 51(4):939-45. PubMed ID: 12654753 [TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF). Tazumi A; Maeda Y; Goldsmith CE; Coulter WA; Mason C; Millar BC; McCalmont M; Rendall J; Elborn JS; Matsuda M; Moore JE J Antimicrob Chemother; 2009 Sep; 64(3):501-6. PubMed ID: 19584106 [TBL] [Abstract][Full Text] [Related]
19. Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial. Wolter J; Seeney S; Bell S; Bowler S; Masel P; McCormack J Thorax; 2002 Mar; 57(3):212-6. PubMed ID: 11867823 [TBL] [Abstract][Full Text] [Related]
20. Sinus fluid penetration of oral clarithromycin and azithromycin in patients with acute rhinosinusitis. Margaritis VK; Ismailos GS; Naxakis SS; Mastronikolis NS; Goumas PD Am J Rhinol; 2007; 21(5):574-8. PubMed ID: 17999793 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]